Snapshot from Jun 09, 2026 at 07:00 UTC. For live data and tracking: View Live
Events / Technology / Oxford develops Bundibugyo Ebola vaccine
Tech vaccine development

Oxford develops Bundibugyo Ebola vaccine

Analysis based on 8 articles · First reported May 22, 2026 · Last updated May 22, 2026

Sentiment
70
Attention
6
Articles
8
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The rapid development of a vaccine for the Bundibugyo ebolavirus by University of Oxford, with mass production by Serum Institute of India, could positively impact pharmaceutical and biotechnology stocks involved in vaccine research and manufacturing. The outbreak in the Democratic Republic of the Congo, however, poses a negative risk to regional economies and public health, potentially affecting travel and trade.

pharmaceuticals biotechnology healthcare
Event Summary

Scientists at University of Oxford are urgently developing a new vaccine for the Bundibugyo ebolavirus, a rare species of Ebola causing an outbreak in the Democratic Republic of the Congo. This outbreak has resulted in 750 suspected cases and 177 deaths, prompting the World Health Organization to declare a public health emergency and upgrade the risk level in the Democratic Republic of the Congo to 'very high'. The vaccine utilizes the ChAdOx1 technology, previously used for Covid-19, and is being prepared with genetic code from the Bundibugyo ebolavirus. Animal testing is underway, and the Serum Institute of India is prepared for mass production once medical-grade material is available. The World Health Organization anticipates the vaccine could be ready for clinical trials in two to three months. The United Kingdom and the United Nations have committed significant financial aid to support containment efforts in the affected region, which also includes Uganda.

Key Actions
90 World Health Organization notified incident
85 World Health Organization revised risk assessment Democratic Republic of the Congo
70 Serum Institute of India lined up to produce
60 United Kingdom provided funding Democratic Republic of the Congo
40 United Nations released funds
Entities Involved
cnt
Democratic Republic of the Congo
The Democratic Republic of the Congo is the epicenter of the current Ebola outbreak, with a 'very high' risk of spread within its borders. The outbreak has led to numerous suspected cases and deaths, impacting public health and potentially its economy.
Importance 90 Sentiment -60
ngo
World Health Organization
The World Health Organization declared a public health emergency of international concern due to the Ebola outbreak and upgraded the risk level in the Democratic Republic of the Congo. It is coordinating the international response and providing guidance on vaccine development and deployment.
Importance 85 Sentiment 50
per
Teresa Lambe
Professor Teresa Lambe, Calleva Head of Vaccine Immunology at the University of Oxford Vaccine Group, is a lead scientist in the development of the new Ebola vaccine. Her expertise is crucial to the project's success.
Importance 80 Sentiment 70
priv
Serum Institute of India
The Serum Institute of India is poised to mass produce the Ebola vaccine once University of Oxford can provide medical-grade material. This positions them as a key player in global vaccine supply.
Importance 70 Sentiment 60
cnt
United Kingdom
The United Kingdom is providing up to £20 million to contain the Ebola outbreak in the Democratic Republic of the Congo and Uganda, supporting international efforts and frontline health workers.
Importance 60 Sentiment 30
per
Tedros Adhanom Ghebreyesus
Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization, has been instrumental in declaring the public health emergency and communicating the escalating risk of the Ebola outbreak.
Importance 60 Sentiment 50
cnt
Uganda
Uganda has experienced previous outbreaks of the Bundibugyo ebolavirus and is part of the wider region where the risk of the current Ebola outbreak is considered high. It will receive financial aid from the United Kingdom.
Importance 40 Sentiment -30
alliance
United Nations
The United Nations released $60 million from its Central Emergency Response Fund to accelerate the response to the Ebola outbreak in the region, providing crucial financial support.
Importance 40 Sentiment 30
govactor
European Union — European Medicines Agency
The European Union — European Medicines Agency approved a different Ebola vaccine in 2020, demonstrating its role in regulating and approving medical treatments.
Importance 20 Sentiment 20
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.